143 related articles for article (PubMed ID: 32140662)
1. Novel Liquid Biopsy Test Based on a Sensitive Methylated
Kotoh Y; Suehiro Y; Saeki I; Hoshida T; Maeda M; Iwamoto T; Matsumoto T; Hidaka I; Ishikawa T; Takami T; Higaki S; Fujii I; Suzuki C; Shindo Y; Tokumitsu Y; Nagano H; Sakaida I; Yamasaki T
Hepatol Commun; 2020 Mar; 4(3):461-470. PubMed ID: 32140662
[TBL] [Abstract][Full Text] [Related]
2. Methylated SEPT9 assay-based liquid biopsy as a biomarker in molecular targeted agent-treated hepatocellular carcinoma.
Saeki I; Suehiro Y; Yamauchi Y; Hoshida T; Tanabe N; Oono T; Kawamoto D; Nishimura T; Matsumoto T; Ishikawa T; Shimokawa M; Tamori A; Kawada N; Tamai Y; Iwasa M; Nakagawa H; Nagano H; Takami T; Yamasaki T
Hepatol Int; 2023 Oct; 17(5):1289-1299. PubMed ID: 37186217
[TBL] [Abstract][Full Text] [Related]
3. Validation of a real-time PCR-based qualitative assay for the detection of methylated SEPT9 DNA in human plasma.
Potter NT; Hurban P; White MN; Whitlock KD; Lofton-Day CE; Tetzner R; Koenig T; Quigley NB; Weiss G
Clin Chem; 2014 Sep; 60(9):1183-91. PubMed ID: 24938752
[TBL] [Abstract][Full Text] [Related]
4. Application of droplet digital polymerase chain reaction of plasma methylated septin 9 on detection and early monitoring of colorectal cancer.
Ma ZY; Chan CSY; Lau KS; Ng L; Cheng YY; Leung WK
Sci Rep; 2021 Dec; 11(1):23446. PubMed ID: 34873218
[TBL] [Abstract][Full Text] [Related]
5. SEPT9 Expression in Hepatic Nodules: An Immunohistochemical Study of Hepatocellular Neoplasm and Metastasis.
Kmeid M; Park YN; Chung T; Pacheco RR; Arslan ME; Lee H
Appl Immunohistochem Mol Morphol; 2023 May-Jun 01; 31(5):278-287. PubMed ID: 36867734
[TBL] [Abstract][Full Text] [Related]
6. Performance Comparison Between Plasma and Stool Methylated
Liu Y; Zhao G; Miao J; Li H; Ma Y; Liu X; Li S; Zhu Y; Xiong S; Zheng M; Fei S
Front Genet; 2020; 11():324. PubMed ID: 32373158
[TBL] [Abstract][Full Text] [Related]
7. Circulating methylated SEPT9 DNA in plasma is a biomarker for colorectal cancer.
deVos T; Tetzner R; Model F; Weiss G; Schuster M; Distler J; Steiger KV; Grützmann R; Pilarsky C; Habermann JK; Fleshner PR; Oubre BM; Day R; Sledziewski AZ; Lofton-Day C
Clin Chem; 2009 Jul; 55(7):1337-46. PubMed ID: 19406918
[TBL] [Abstract][Full Text] [Related]
8. Performance of the colorectal cancer screening marker Sept9 is influenced by age, diabetes and arthritis: a nested case-control study.
Ørntoft MB; Nielsen HJ; Ørntoft TF; Andersen CL;
BMC Cancer; 2015 Oct; 15():819. PubMed ID: 26514170
[TBL] [Abstract][Full Text] [Related]
9. Detection of Colorectal Cancer Using a Simplified SEPT9 Gene Methylation Assay Is a Reliable Method for Opportunistic Screening.
Wu D; Zhou G; Jin P; Zhu J; Li S; Wu Q; Wang G; Sheng J; Wang J; Song L; Han X; Qian J
J Mol Diagn; 2016 Jul; 18(4):535-45. PubMed ID: 27133379
[TBL] [Abstract][Full Text] [Related]
10. Blood Free-Circulating DNA Testing of Methylated RUNX3 Is Useful for Diagnosing Early Gastric Cancer.
Hideura E; Suehiro Y; Nishikawa J; Shuto T; Fujimura H; Ito S; Goto A; Hamabe K; Saeki I; Okamoto T; Higaki S; Fujii I; Suzuki C; Hoshida T; Matsumoto T; Takami T; Sakaida I; Yamasaki T
Cancers (Basel); 2020 Mar; 12(4):. PubMed ID: 32224873
[TBL] [Abstract][Full Text] [Related]
11. The performance of the mSEPT9 assay is influenced by algorithm, cancer stage and age, but not sex and cancer location.
Song L; Jia J; Yu H; Peng X; Xiao W; Gong Y; Zhou G; Han X; Li Y
J Cancer Res Clin Oncol; 2017 Jun; 143(6):1093-1101. PubMed ID: 28224298
[TBL] [Abstract][Full Text] [Related]
12. Colorectal cancer screening with blood-based biomarkers: cost-effectiveness of methylated septin 9 DNA versus current strategies.
Ladabaum U; Allen J; Wandell M; Ramsey S
Cancer Epidemiol Biomarkers Prev; 2013 Sep; 22(9):1567-76. PubMed ID: 23796793
[TBL] [Abstract][Full Text] [Related]
13. Blood free-circulating DNA testing by highly sensitive methylation assay to diagnose colorectal neoplasias.
Suehiro Y; Hashimoto S; Higaki S; Fujii I; Suzuki C; Hoshida T; Matsumoto T; Yamaoka Y; Takami T; Sakaida I; Yamasaki T
Oncotarget; 2018 Mar; 9(24):16974-16987. PubMed ID: 29682198
[TBL] [Abstract][Full Text] [Related]
14. Circadian Rhythm of Methylated Septin 9, Cell-Free DNA Amount and Tumor Markers in Colorectal Cancer Patients.
Tóth K; Patai ÁV; Kalmár A; Barták BK; Nagy ZB; Galamb O; Wichmann B; Tulassay Z; Molnár B
Pathol Oncol Res; 2017 Jul; 23(3):699-706. PubMed ID: 28035516
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of the cell-free DNA integrity index as a liquid biopsy marker to differentiate hepatocellular carcinoma from chronic liver disease.
Kumar S; Nadda N; Paul S; Gamanagatti S; Dash NR; Vanamail P; Saraya A; Shalimar ; Nayak B
Front Mol Biosci; 2022; 9():1024193. PubMed ID: 36483538
[No Abstract] [Full Text] [Related]
16. The SEPT9 gene methylation assay is capable of detecting colorectal adenoma in opportunistic screening.
Song L; Peng X; Li Y; Xiao W; Jia J; Dong C; Gong Y; Zhou G; Han X
Epigenomics; 2017 May; 9(5):599-610. PubMed ID: 28470092
[TBL] [Abstract][Full Text] [Related]
17. Detection of methylated septin 9 in tissue and plasma of colorectal patients with neoplasia and the relationship to the amount of circulating cell-free DNA.
Tóth K; Wasserkort R; Sipos F; Kalmár A; Wichmann B; Leiszter K; Valcz G; Juhász M; Miheller P; Patai ÁV; Tulassay Z; Molnár B
PLoS One; 2014; 9(12):e115415. PubMed ID: 25526039
[TBL] [Abstract][Full Text] [Related]
18. Epi proColon
Lamb YN; Dhillon S
Mol Diagn Ther; 2017 Apr; 21(2):225-232. PubMed ID: 28155091
[TBL] [Abstract][Full Text] [Related]
19. From discovery to the clinic: the novel DNA methylation biomarker (m)SEPT9 for the detection of colorectal cancer in blood.
Payne SR
Epigenomics; 2010 Aug; 2(4):575-85. PubMed ID: 22121975
[TBL] [Abstract][Full Text] [Related]
20. The role of
Sun J; Fei F; Zhang M; Li Y; Zhang X; Zhu S; Zhang S
BMC Cancer; 2019 May; 19(1):450. PubMed ID: 31088406
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
